Effect of Dapagriflozin on renal dysfunction in patients with heart failure
Not Applicable
Recruiting
- Conditions
- chronic heart failure
- Registration Number
- JPRN-UMIN000044902
- Lead Sponsor
- Mitsui Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindications in the attached text
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of changes in renal function and renal damage markers at the admission of dapagriflozin, at 2 weeks, and at 2 month
- Secondary Outcome Measures
Name Time Method Relationship between renal function and renal damage markers and 1-year composite endpoint (eGFR decline, end-stage renal failure, heart failure hospitalization, and death) Changes in QTc dispersion